Trends of MBT drug resistance

L. Pankratova, I. Volchkova (Saratov, Russian Federation)

Source: Annual Congress 2013 –Tuberculosis: epidemiology and public health management I
Session: Tuberculosis: epidemiology and public health management I
Session type: Thematic Poster Session
Number: 2864
Disease area: Respiratory infections

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
L. Pankratova, I. Volchkova (Saratov, Russian Federation). Trends of MBT drug resistance. Eur Respir J 2013; 42: Suppl. 57, 2864

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Drug resistance among new TB cases in some Russian regions
Source: International Congress 2015 – Epidemiology of TB: deaths, co-morbidities, migration and children
Year: 2015


Impact of drug injection using on TB-AIDS treatment outcomes
Source: Annual Congress 2013 –Tuberculosis: epidemiology and public health management I
Year: 2013

Tuberculosis and HIV infection in combination with multidrug resistant MBT on Northwest of Russia
Source: International Congress 2016 – Epidemiological aspects of tuberculosis and other respiratory conditions: from lung cancer to late-onset Pompe's disease
Year: 2016

Range of additional drug resistance of M.tuberculosis in XDR-TB patients
Source: International Congress 2016 – Update on drug-resistant tuberculosis
Year: 2016


Drug resistant tuberculosis in urban hotspot
Source: International Congress 2014 – Mycobacterium tuberculosis infection and disease: clinical epidemiology 1
Year: 2014


Tuberculosis (TB) and depression
Source: Annual Congress 2013 –Tuberculosis: clinical aspects
Year: 2013

Detection of tuberculosis in children
Source: Annual Congress 2013 –Tuberculosis: epidemiology and public health management II
Year: 2013


Genotypes of mycobacterium tuberculosis with pre-extended drug resistance in Belarus
Source: International Congress 2016 – New insights into aspects of tuberculosis epidemiology
Year: 2016

Risk factors for anti-TB drug resistance in Poland
Source: Annual Congress 2013 –Tuberculosis: epidemiology and public health management III
Year: 2013

Statin use and the risk of tuberculosis: Data from 305,142 patients
Source: International Congress 2016 – New insights into aspects of tuberculosis epidemiology
Year: 2016


Differential characteristics of tuberculosis among immigrants
Source: Annual Congress 2013 –Tuberculosis: clinical epidemiology and public health
Year: 2013


Features of pulmonary tuberculosis in migrants
Source: International Congress 2015 – Epidemiology of TB: deaths, co-morbidities, migration and children
Year: 2015

Factors contributing to drug-resistant tuberculosis in the Luton, UK
Source: Annual Congress 2013 –Tuberculosis: clinical epidemiology and public health
Year: 2013


Spreading of tuberculosis with extensive drug resistant MBTin Northwest region of Russia
Source: International Congress 2014 – Mycobacterium tuberculosis infection and disease: clinical epidemiology 1
Year: 2014

Risk factors for acquired drug-resistant tuberculosis
Source: Annual Congress 2013 –Drug-resistant tuberculosis
Year: 2013

Spectrum of urogenital tuberculosis
Source: Annual Congress 2013 –Tuberculosis: clinical aspects
Year: 2013

Gender differences in active tuberculosis
Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 3
Year: 2014

Dynamics of MBT drug resistance in Saratov Region Hospital, Russia
Source: International Congress 2016 – Epidemiological insights into tuberculosis pathogenesis
Year: 2016

Aspects of TB endemia in Bucharest
Source: International Congress 2015 – Management of TB: a patient focus
Year: 2015

How to recognize kidney tuberculosis
Source: International Congress 2014 – Mycobacterium tuberculosis infection and disease: clinical epidemiology 2
Year: 2014